WRI 2003

The 2003 Women and HIV Think Tank meeting was the first of its kind convened by The Well Project, an organization formed in 2001, dedicated to reducing the total human cost of the AIDS pandemic through a unique focus on women.

The Think Tank was designed to identify the gaps and controversies in research on women and HIV, develop research questions, and consolidate Pharma Advisory Board meetings without excluding industry from interaction and feedback. This goal was intentionally broad allowing the participants to determine what the needs are rather than imposing a specific focus on the group. The invitees and participants represented a diverse body of expertise ranging from microbiology to epidemiology and basic research to clinical management. All of the participants impact research (from funding to implementation) or manage women with HIV in a clinical setting, with a significant percentage doing both. Please scroll down for a list of 2003 participants.

The Well Project pledged to broadly disseminate this Think Tank Meeting Summary Report, actively seek interest in the list of research questions, and develop additional educational materials based on the findings of the first Women and HIV Think Tank meeting.

For the full 2003 meeting report, please click the link below.

2003 Women and HIV Think Tank Participants

Kathryn Anastos, MD 
Montefiore Medical Center, Albert Einstein College of Medicine
Judith D. Auerbach, PhD 
Vice President, Public Policy
amfAR
Dawn Averitt Bridge 
Founder
The Well Project
Arlene Bardeguez, MD, MPH, FACOG 
Associate Professor, Director HIV
New Jersey Medical School, Department of OB-GYN
Gina Brown, MD 
Cicatelli Associates, Inc.
Terri Creagh, PhD 
Clinical and Epidemiologic Research 
Judith Currier, MD 
University of California Los Angeles Care Center 
Rebecca Denison 
WORLD
Jeanne Dumestre, NP 
Louisiana State University Health Sciences Center
Sharon Lee, MD 
Southwest Boulevard Family Health Care Center
Veronica Miller, PhD 
Director
Forum for Collaborative HIV Research
Levonne Mitchell-Samon, MD 
University of Florida
Karin Nielsen, MD, MPH 
Associate Clinical Professor, Pediatric Infectious Diseases
UCLA Department of Pediatrics
Andrew Pavia, MD 
Professor of Pediatrics and Medicine
University of Utah
Tonia Poteat, PA-C 
Grady Health System
Jennifer Trauscht VanHorne, MD 
Department of OB-GYN
University of Utah
Fulvia Veronese, PhD 
National Institutes of Health
 

Women and HIV Think Tank 2003 List of Pharmaceutical Representatives 

Susan Conner
Kay Mitzel

Agouron-Pfizer 

Christopher Dezii
Donne Newbury

Bristol-Myers Squibb

Keri Oberg
Boehringer Ingelheim

David Frey
Christina Hill-Zabala
Karen Moldt
Kim Williams

GlaxoSmithKline

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name

Obtener información acerca de las razones las mujeres mayores se pasan por alto a pesar de estar en riesgo de contraer el VIH, cómo el conocimiento es poder, y la importancia de hacerse la prueba.

Learn what opportunistic infections (OIs) are, including specifics about nine OIs, how people get them, and how to treat and prevent them.

Where are we with finding a cure for HIV, and why is it taking so long? Learn answers to these questions and find out more about current cure research strategies.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>